Adaptimmune Therapeutics PLC (ADAPY) vs NewcelX Ltd. (NCEL)
- Adaptimmune Therapeutics PLC ADAPY 0.03 0.00%
- NewcelX Ltd. NCEL 2.61 −2.97%
Adaptimmune Therapeutics PLC and NewcelX Ltd. are both Biotechnology companies. Adaptimmune Therapeutics PLC and NewcelX Ltd. are of similar size ($14.6M and $14.5M). NewcelX Ltd. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Adaptimmune Therapeutics PLC leads on 5 and NewcelX Ltd. on 5.
Valuation
Profitability
| Metric | ADAPY | NCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.81% | 0.00% | 67.24% |
| Operating margin | (427.75%) | — | 0.00% |
| Net margin | (262.46%) | 0.00% | 0.00% |
| Free cash flow margin | (294.49%) | 0.00% | 0.00% |
| Return on equity | (1,349.52%) | 0.00% | (50.28%) |
| Return on assets | 0.00% | 0.00% | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack